Johanna Veldman
4PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Oct 10, 2025
Programmed cell death-1 inhibition activates CD4 T cells in a novel in vitro model of Hodgkin lymphoma.Rodrigo Martinez Alcala, Yajie Lei, Lydia Visser
|Sep 29, 2021
Reverted exhaustion phenotype of circulating lymphocytes as immune correlate of anti-PD1 first-line treatment in Hodgkin lymphoma.Maria A Garcia-Marquez, Martin Thelen, Sarah Reinke
|Sep 14, 2021
9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial.Elena Gerhard-Hartmann, Helen Goergen, Paul J Bröckelmann
|Feb 23, 2021
Soluble PD-L1 is a promising disease biomarker but does not reflect tissue expression in classic Hodgkin lymphoma.Johanna Veldman, Zainab N D Alsada, Anke van den Berg
Pageof 1
Frequent Collaborators
4 joint publications
Arjan Diepstra
2 joint publications
Wolfram Klapper
1 joint publications
Wouter J Plattel
1 joint publications
Elena Gerhard-Hartmann
1 joint publications
Sven Borchmann
1 joint publications
Maria A Garcia-Marquez
1 joint publications
Martin Thelen
1 joint publications
Paul J Bröckelmann
1 joint publications
Rodrigo Martinez Alcala
1 joint publications
Yajie Lei
